Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma

被引：0
|
作者：
Liu, Wei
Huang, Wenyang
Lv, Ryu
Deng, Shuhui
Yi, Shuhua
Liu, Huimin
Lv, Lulu
Qiu, Lugui
Zou, Dehui
Wang, Jianxiang
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139351
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphoma
    Wen Lei
    Ai Zhao
    Hui Liu
    Chunmei Yang
    Cheng Wei
    Shanshan Guo
    Zhilu Chen
    Qunyi Guo
    Linjie Li
    Mingzhe Zhao
    Gongqiang Wu
    Guifang Ouyang
    Ming Liu
    Jinyi Zhang
    Jimin Gao
    Wenbin Qian
    Cell Discovery, 10
  • [22] Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma
    Abramson, Jeremy S.
    Irwin, Kelly E.
    Frigault, Matthew J.
    Dietrich, Jorg
    McGree, Brianne
    Jordan, Justin T.
    Yee, Andrew J.
    Chen, Yi-Bin
    Raje, Noopur S.
    Barnes, Jeffrey A.
    Davis, Benjamin
    CANCER, 2019, 125 (21) : 3692 - 3698
  • [23] Overcoming resistance to anti-CD19 CAR T-cell therapy in B-cell malignancies
    Yang, Xingcheng
    Wei, Jia
    Zhou, Jianfeng
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 821 - 834
  • [24] HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma
    Bourbon, Estelle
    Sesques, Pierre
    Gossez, Morgane
    Tordo, Jeremie
    Ferrant, Emmanuelle
    Safar, Violaine
    Wallet, Florent
    Aussedat, Guillaume
    Maarek, Alizee
    Boua, Fadhela
    Karlin, Lionel
    Ghergus, Dana
    Golfier, Camille
    Lequeu, Helene
    Lazareth, Anne
    Schwiertz, Verane
    Viel, Sebastien
    Idlhaj, Maryam
    Ghesquieres, Herve
    Monneret, Guillaume
    Bachy, Emmanuel
    Venet, Fabienne
    BLOOD ADVANCES, 2023, 7 (05) : 744 - 755
  • [25] Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving Anti-CD19 CAR T-cell Therapy
    Jodon, Gray
    Colton, Meryl D.
    Abbott, Diana
    Cai, Anthony
    Haverkos, Bradley
    Morgan, Rustain
    Kamdar, Manali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : 49 - 56
  • [26] Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Xu, Yingxi
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    BLOOD, 2019, 134
  • [27] Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Davis, James A.
    Shockley, Abigail
    Glode, Ashley E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (03) : 686 - 690
  • [28] Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma
    Baidoun, Firas
    Merjaneh, Zahi
    Abd-Elhay, Fatma Abd-Elshahed
    Kamel, Mohamed Gomaa
    TRANSLATIONAL ONCOLOGY, 2021, 14 (09):
  • [29] Outcomes and Treatment Patterns in Patients with Aggressive B-Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy
    Zurko, Joanna C.
    Epperla, Narendranath
    Nizamuddin, Imran
    Torka, Pallawi
    David, Kevin A.
    Ollila, Thomas A.
    Hess, Brian T.
    Cohen, Jonathon B.
    Ferdman, Robert
    Liu, Jieqi
    Chowdhury, Sayan Mullick
    O'Shea, Kaitlyn
    Romancik, Jason
    Bhansali, Rahul
    Harris, Elyse
    Sorrell, Mckenzie
    Masel, Rebecca
    Fitzgerald, Lindsey
    Galvez, Carlos
    Ma, Shuo
    Winter, Jane N.
    Pro, Barbara
    Gordon, Leo I.
    Danilov, Alexey V.
    Stephens, Deborah M.
    Shah, Nirav N.
    Shouse, Geoffrey
    Kenkre, Vaishalee P.
    Barta, Stefan K.
    Karmali, Reem
    BLOOD, 2021, 138
  • [30] CAR T-Cell Therapy for Relapsed/Refractory Aggressive Large B-Cell Lymphoma
    Gideon, Jacklyn
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (06) : 597 - 601
12345